Our previous study reveals that FLT3-ITD and MLL-AF9 oncogenes, which present with a high leukemic burden and confer a poor prognosis in patients with AML, contributed to the silencing of GADD45g in AML10. The gene discussed is KMT2A; the disease is acute myeloid leukemia.